Related Experiment Videos
Interaction of fluconazole with cyclosporin
Lancet (London, England)
|July 8, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Acquired von Willebrand syndrome in congenital heart disease surgery: results from an observational case-series.
Journal of thrombosis and haemostasis : JTH·2018
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
An optimized targeted Next-Generation Sequencing approach for sensitive detection of single nucleotide variants.
Biomolecular detection and quantification·2018
What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
Journal of internal medicine·2017
Ambient scribes as narrative technologies.
Lancet (London, England)·2026
Barriers to access to over-the-counter oral contraceptives by neighborhood social vulnerability in Boston, Massachusetts.
Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives·2026
Phosphonium Chloride-Enhanced Ionization for High-Throughput Screening and Imaging of Carbohydrate Metabolites: Unveiling Disruptors of Sugar Metabolism.
Environmental science & technology·2026
Oxygenated 9H-carbazole-3-carbaldehyde scaffolds as cerebral cavernous malformation-relevant protein-protein interaction disruptors of the HEG1-KRIT1 interface.
Journal of computer-aided molecular design·2026
Halogenated Tryptophans Improve Integrin αVβ6 Affinity of Cyclic RGD Peptides and Provide Handles for Late-Stage Derivatization.
Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Affinity Peptide-Driven Precision Glycan Analysis: From Targeted Capture to Single-Molecule Profiling.
Accounts of chemical research·2026
Urinary Glucose Concentration as a Predictor of Proteinuria Reduction in Chronic Kidney Disease Patients Treated with Sodium-Glucose Cotransporter 2 Inhibitors.
Kidney diseases (Basel, Switzerland)·2026